Relaxin does not improve Angiotensin II-induced target-organ damage.
Relaxin is a corpus-luteum produced protein hormone with vasodilatatory, anti-fibrotic, and angiogenic properties that are opposite to angiotensin (Ang) II. We investigated whether or not relaxin ameliorates Ang II-induced target-organ damage. We used double transgenic rats harboring both human reni...
Guardado en:
Autores principales: | Nadine Haase, Julianna Rugor, Lukasz Przybyl, Fatimunnisa Qadri, Dominik N Müller, Ralf Dechend |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed96280a03b74b10bf01a59306c3446f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
por: Shoni Bruell, et al.
Publicado: (2017) -
Development of a selective agonist for relaxin family peptide receptor 3
por: Dian Wei, et al.
Publicado: (2017) -
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
por: Mengying Hu, et al.
Publicado: (2019) -
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
por: Martina Kocan, et al.
Publicado: (2017) -
Angiotensin II type 1a receptor loss ameliorates chronic tubulointerstitial damage after renal ischemia reperfusion
por: Yoko Fujita, et al.
Publicado: (2021)